CAR T-cell therapy may cure up to 40% of patients with lymphoma and is an option for those who can’t receive transplants, ...

Mansi Shah, MD, explains how treatment sequencing and patient eligibility guide the use of these therapies in multiple ...

While presenting the data at this year's American Society of Clinical Oncology (ASCO) annual meeting, Peter Voorhees, MD, of ...

Like many closely-knit mothers and daughters, Noreen and Anne Hennessy love nothing more than hitting the shops together at ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 ...

Background. Multiple myeloma is a type of blood cancer. It accounts for approximately 2% of all cancers and is still considered incurable. For people with newly diagnosed multiple myeloma (NDMM), who ...

For many, a stem cell transplant from a matching donor is their best chance at survival. But finding a match is like searching for a needle in a haystack. Thando’s story: From dancing to diagnosis.

Idecabtagene vicleucel (ide-cel; Abecma) showed impressive efficacy and a manageable safety profile in patients with multiple myeloma with suboptimal responses after upfront autologous hematopoietic ...

A UK clinical study suggests that children undergoing allogeneic haematopoietic stem cell transplant (HSCT) may safely tolerate lower levels of anaemia than current practice assumes.. Researchers ...

At 38, author Jonathan Gluck was diagnosed with blood cancer and given less than three years to live. Twenty-two years later, ...